# The Osteoporosis Drugs Market To Supersede Based On Innovation
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-26
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global Osteoporosis Drugs Market Growth Analysis: 2021-2031
Meta Description: Stay informed about the latest trends and growth opportunities in the global osteoporosis drugs market. Get detailed insights and forecasts till 2031.
URL: https://financedigest.com/the-osteoporosis-drugs-market-to-supersede-based-on-innovationhtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836877769-compressed.jpg)

The [**global osteoporosis drugs market**](https://www.persistencemarketresearch.com/market-research/osteoporosis-drugs-market.asp) is valued at **US$ 12.5 Bn** at present, and is expected to progress at a modest **CAGR of 3.8%** from 2021 to 2031, to account for **US$ 18 Bn** by 2031.

The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in [drug discovery and development are also driving the growth of the market](https://www.financedigest.com/the-peptic-ulcer-drugs-market-to-proliferate-with-digitized-upswing.html "The Peptic Ulcer Drugs Market to proliferate with digitized upswing").

However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the [growth of the market](https://www.financedigest.com/innovative-apps-to-foster-the-growth-of-autogenous-vaccine-for-aquaculture-market.html "Innovative apps to foster the growth of Autogenous Vaccine For Aquaculture Market").

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/2983**](https://www.persistencemarketresearch.com/samples/2983)

**Company Profiles:**

- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Merck & Co, Inc.
- Novartis AG
- Amgen, Inc.
- [Novo Nordisk](https://www.financedigest.com/novo-nordisk-in-talks-buy-controlling-stake-in-biocorp.html "Novo Nordisk in talks buy controlling stake in Biocorp") A/S
- Actavis plc
- Pfizer, Inc.
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd

**Request for Methodology@** [**https://www.persistencemarketresearch.com/methodology/2983**](https://www.persistencemarketresearch.com/methodology/2983)

In North America, the [prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases](https://www.financedigest.com/title-europe-direct-to-consumer-laboratory-testing-market-to-exhibit-26-cagr-by-2031-increasing-geriatric-population-and-growing-prevalence-of-infectious-diseases.html "Europe Direct-to-Consumer Laboratory Testing Market to Exhibit 26% CAGR by 2031; Increasing Geriatric Population and Growing Prevalence of Infectious Diseases") in the region.

According to the U.S. [Department of Health](https://www.financedigest.com/baswares-e-invoicing-to-eliminate-inefficiencies-in-health-department.html "Basware’s e-invoicing to eliminate inefficiencies in Health Department") and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.

In Europe, [increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market](https://www.financedigest.com/increasing-incidences-of-spinal-fractures-to-drive-the-osteoporosis-drugs-market.html "Increasing incidences of spinal fractures to drive the Osteoporosis Drugs Market").

According to [International Osteoporosis Foundation](https://www.financedigest.com/trust-the-foundation-of-international-remote-working-culture.html "Trust: The foundation of international remote working culture"), approximately 27.5 million people in Europe suffered from osteoporosis in 2010, and the number is expected to reach 33.9 Mn by 2030.

However, the growth of osteoporosis [market in Asia Pacific is much due to rising](https://www.financedigest.com/ott-content-market-to-rise-to-a-valuation-of-us-245814-4-mn.html "OTT Content Market to rise to a valuation of US$ 245,814.4 Mn") geriatric population and changing lifestyles in the region. Osteoporotic patients have a [higher risk](https://www.financedigest.com/dollar-higher-on-risk-aversion-euro-revisits-parity.html "Dollar higher on risk aversion; euro revisits parity") of hip fractures, owing to a major cause of morbidity and mortality.

According to the International Osteoporosis Foundation, by 2050, approximately 1/2 of the [world’s osteoporosis hip fractures would occur in women](https://www.financedigest.com/why-the-world-needs-more-women-controlling-the-money.html "Why the world needs more women controlling the money") in Asia.

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/2983**](https://www.persistencemarketresearch.com/checkout/2983)

**Market Segmentation:**

**By Drug Type**

- Bisphosphonates
- Parathyroid Hormone Therapy Drugs
- Calcitonin
- Selective Estrogen Receptors Modulators (SERMs)
- RANK Ligand Inhibitors

**[Related](https://www.financedigest.com/aonponemon-report-almost-four-times-more-budget-is-being-spent-on-property-related-risks-vs-cyber-risk.html "Aon/Ponemon report: Almost four times more budget is being spent on property related risks vs. cyber risk") Reports:**

[**Dysphagia Management Market**](https://www.persistencemarketresearch.com/market-research/dysphagia-management-market.asp)

[**Insomnia Treatment Market**](https://www.persistencemarketresearch.com/market-research/insomnia-treatment-market.asp)

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**[Persistence Market](https://www.financedigest.com/the-pharmaceutical-packaging-market-to-stay-innovatively-persistent.html "The Pharmaceutical Packaging Market to stay innovatively persistent") Research**

Address – 305 Broadway, 7th Floor, New [York City](https://www.financedigest.com/drorfutter-joins-rimon-as-partner-in-its-new-jersey-and-new-york-city-offices.html "DrorFutter, joins Rimon as Partner in its New Jersey and New York City offices"),

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca [Central Building](https://www.financedigest.com/bosch-to-build-215-million-plant-in-central-mexico.html "Bosch to build 5 million plant in central Mexico")

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---